Skip to main content

Table 3 Nipple aspirate fluid (NAF) cytologic findings

From: Cytologic features of nipple aspirate fluid using an automated non-invasive collection device: a prospective observational study

Cytologic diagnosis

No. of women/Total No. fluid producers (%)

18–24 yr, No. (%)

25–34 yr, No. (%)

35–44 yr, No. (%)

45–54 yr, No. (%)

55–64, No. (%)

65 + yrs, No. (%)

Unsatisfactory (Category 0)

93/187 (49.7)

9/93 (9.7)

14/93 (15.1)

22/93 (23.7)

32/93 (34.4)

15/93 (16.1)

1/93 (1.1)

Benign (Category I)

71/187 (38.0)

5/71 (7.0)

15/71 (21.1)

21/71 (29.6)

25/71 (35.2)

5/71 (7.0)

0

Hyperplasia (Category II)

18/187 (9.6)

1/18 (5.6)

6/18 (33.3)

1/18 (5.6)

5/18 (27.8)

5/18 (27.8)

0

Atypical Hyperplasia (Category III)

5/187 (2.8)

1/5 (20.0)

0

1/5 (20.0)

2/5 (40.0)

0

1/5 (20.0)

Malignancy (Category IV)

0/187 (0.0)

0

0

0

0

0

0

Sample Leak

3/187 (1.6)

0

1

0

1

1

0